586-IgG1 Plasma Cell Responses to Immune Checkpoint Blockade

This research highlights the essential role of humoral immunity in determining the success of immune checkpoint blockade (ICB) therapy across various cancers, particularly hepatocellular carcinoma. The study identifies that patients who respond well to treatment exhibit a significant expansion of IgG1-secreting plasma cells and specialized B cell niches within the tumor environment. These benefici...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动